Our guides on GLP-1 friendly meals and breakfast ideas focus on practical, protein-forward meal strategies
Participants also recorded reductions in waist circumference (average 7.1cm loss on 6mg, 8.2cm on 12mg, 10cm on 36mg, compared with 3.1cm loss on placebo), blood pressure (estimated -4.2 and -1mm HG difference between placebo and orforglipron in systolic and diatolic blood pressure, respectively) and cholesterol (-2.1% difference between placebo and orforglipron)
Results may vary To see if GLP-1 resistance translated into therapeutic differences, researchers examined data from several clinical trials of GLP-1 receptor agonists in people with diabetes
And while its important to be aware of possible side effects, severe gastrointestinal conditions like gastroparesis have not been linked to this medication
JAMA (2019) 321:1457
The rate of osteoporosis, a disease where the bones become fragile and brittle, was 3.2% in the group not taking the drug, compared to 4.1% in the GLP-1-taking group